학술논문

509MO Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01.
Document Type
Article
Source
Annals of Oncology. 2023 Supplement 4, Vol. 34, pS1665-S1666. 2p.
Subject
*NON-small-cell lung carcinoma
*DOCETAXEL
*METASTASIS
Language
ISSN
0923-7534